NeuralTeks
PrivateLast Round
Seed
Jan 29, 2025
Est. Valuation
$3M
Total Funding Raised
$240,000
Company Overview
NeuralTeks operates in Enterprise Software and is based in Neuilly-sur-Seine. Its latest recorded funding round was an Accelerator round in November 2024.
NeuralTeks is a healthtech company that develops an AI-driven multimodal platform for laboratory image analysis to enhance microbiological studies.
Sector
Enterprise Software
Verticals
Workflow Automation, E-commerce
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuralTeks Comparables
Compare NeuralTeks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImageProVision Technology Pvt. Ltd. | 45% |
For institutional investors. Book with your work email.
NeuralTeks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 29, 2025 | ||||
| Accelerator | Nov 6, 2024 | ||||
| Accelerator | Sep 9, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuralTeks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Paris Biotech Santé | Seed |
| Techstars | Seed, Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2025
Monthly visitors grew 343% MoM, from 54 to 239.
For institutional investors. Book with your work email.
NeuralTeks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuralTeks's valuation, stock price, and market status.
Is NeuralTeks a public or private company?
NeuralTeks is a private company.
What is the current stock price of NeuralTeks?
NeuralTeks is a private company, so its shares have no public market price. Caplight tracks NeuralTeks's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuralTeks worth (valuation)?
NeuralTeks's valuation is estimated at $3.0M based on funding round data.
Can I buy NeuralTeks stock?
NeuralTeks shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuralTeks's last funding round?
NeuralTeks's most recent funding round was Seed on January 29, 2025.
Who are the main investors in NeuralTeks?
Key investors in NeuralTeks include Techstars.
Will NeuralTeks IPO soon?
No public IPO plans have been announced for NeuralTeks.
How can I track NeuralTeks secondary market activity?
Caplight tracks bids, offers, and trades in NeuralTeks's shares on secondary markets.